Authors: WARNER JO BUSINCO L CASIMIR G DIEPGEN TL KJELLMAN M KNOL K MENARDO JL NASPITZ C WAHN U AGBOTON C DELONGUEVILLE M DEPATOUL MC MEREDITH S VANDEPAER M ALBERTINI M BOURRIER T BAUER CP FRANZ R BELLON G BODART E BONER A FORTUNATI P BOTEY J MARIN AM CAVAGNI G GARDENGHI M CLIFFORD R GRIFFITH H DARRAS JP DEBENEDICTIS H PAZZELLI P DERAEVE LE KEMPINAIRE A DUTAU G RANCE F EICHLER I RATH R FAUQUERT JL PIOLLET A FOOTE KD GRIFFIOEN RW SMITT JHS VANNIEROP JC GRIMFELD A SAHRAOUI F GUILLET MH GUILLET G GUSTAFSSON D EKHOLM L HAMELTEILLAC D DEPROST Y HUTTEGGER I LABBE A LASOBORREGO MT MESAPALOMINO A LECLERCQFOUCART J HEINRICH V LEVER R WARD G LIPSCHUTZ W LIPSCHUTZ B LORETTE G MARGUET C MASI M SPECCHIA F MEGLIO P LUCENTI P MORETTI MT MOLLER C FORSBERG G MUNOZLOPEZ F GINERMUNOZ MT ORANJE AP WOLKERSTORFER A NEIJENS HJ OUDESLUYSMURPHY AM SUKHAI RN PAUL KP KLETTKE U PETRUS M RHABBOUR M POLLOCK J BAIRDSNELL M PREHN A SEGER R RIDOUT S MATTHEWS S RING J ROBERT J SCHAUER U KOHLER S SELIGMANN R DEBEAUFORT C SIMONS FER SPICAK V STALDER JF PHELINE F STRANNEGARD IL TAIEB A LABREZE C VANDERWOUDE JK VANBIERVLIET JP VIELUF D VONPILGRIM G WILLE S WARNER A YOUNG E

Citation: Jo. Warner et al., ALLERGIC FACTORS ASSOCIATED WITH THE DEVELOPMENT OF ASTHMA AND THE INFLUENCE OF CETIRIZINE IN A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL - FIRST RESULTS OF ETAC(R), Pediatric allergy and immunology, 9(3), 1998, pp. 116-124

Authors: DELONGUEVILLE M TASSET C WARNER JO BUSINCO L CASIMIR G DIEPGEN L KJELLMAN M KNOL K MENARDO JL NASPITZ C WAHN U BELLON G BODART E BORRES M STANNEG IL SALA JB BOURRIER T CAVAGNI G GARDENGHI M CLIFFORD RD ROY P DARRAS JP DEBENEDICTIS FM PAZZELLI P DERAEVE LE KEMPINAIRE A DUTAU G RANCE F EICHLER I FAUQUERT JL LABBE A FIOCCHI A FOLSTERHOLST R FOOTE KD FORTUNATI P GRIFFIOEN RW SMITT JHS VANNIEROP JC GRIMFIELD A SAHRAOUI F GUILLET MH GUSTAFSSON D EKHOLM L HUTTEGGER I LECLERCQFOUCART J LEVER R WARD G LIPSCHUTZ W LORETTE G MARGUET C MARTINEZSANIRENEO M MASI M MINIACI A MEGLIO P LUCENTI P MORETTI T MOLLER C FORSBERG G MUNOZLOPEZ F GINER MT NEGELE K ORANJE AP WOLKERSTORFER AW NEIJENS HJ OUDESLUYSMURPHY AM SUKHAI RN PAUL K KLETTKE U PETRUS M RHABBOUR M POLLOCK I PREHN A RIDOUT S TARIQ SM ROBERT J SCHAUER U RIEGER C SELIGMANN R SIMONS FER SPICAK V FUCHS M STALDER JF PHELINE F TAIEB A LABBE L TEILLACHAMEL D VANDERWOUDE JK VANBIERVLIET JP VIELUF D RING J VONPILGRIM G WILLE S WARNER A YOUNG E

Citation: M. Delongueville et al., DETERMINANTS OF TOTAL AND SPECIFIC IGE IN INFANTS WITH ATOPIC-DERMATITIS, Pediatric allergy and immunology, 8(4), 1997, pp. 177-184

Authors: SPICAK V DAB I HULHOVEN R DESAGER JP KLANOVA M DELONGUEVILLE M HARVENGT C

Citation: V. Spicak et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF CETIRIZINE IN INFANTS AND TODDLERS, Clinical pharmacology and therapeutics, 61(3), 1997, pp. 325-330

Authors: LENFANT C KHALTAEV N SHEFFER AL BARTAL M BOUSQUET J CHEN YZ CHUCHALIN AG CLARK TJH DAHL R FABBRI LM HOLGATE ST MAHAPATRA P MAKINO S NASPITZ CK PARTRIDGE MR PAUWELS R SPICAK V TAN WC WEISS KB WOOLCOCK AJ XABAMOKOENA MN ZHONG NS

Citation: C. Lenfant et al., GLOBAL STRATEGY FOR ASTHMA - MANAGEMENT A ND PREVENTION NHLBI WHO WORKSHOP REPORT/, Revue francaise d'allergologie et d'immunologie clinique, 36(6), 1996, pp. 563

Authors: SPICAK V KLANOVA M HULHOVEN R DESAGER JP DELONGUEVILLE M HARVENGT C

Citation: V. Spicak et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF CETIRIZINE IN INFANTS, Journal of allergy and clinical immunology, 95(1), 1995, pp. 197-197